ANN ARBOR, Mich., June 11, 2010 (GLOBE NEWSWIRE) -- Richard J. Powell, M.D., section chief of vascular surgery at the Dartmouth-Hitchcock Medical Center in Lebanon, NH and a principal investigator of the U.S. Phase 2b RESTORE-CLI clinical trial sponsored by Aastrom Biosciences (Nasdaq:ASTM), will present the full results from the interim analysis at today's session of the annual meeting of the Society for Vascular Surgery. Dr. Powell's presentation will include additional results from the interim analysis showing that the trial reached statistical significance on amputation-free survival in patients with critical limb ischemia (CLI), a key criterion used by the FDA to evaluate the effectiveness of investigative treatments for CLI.
